Obesity hypoventilation syndrome: a current review.
Rodolfo Augusto Bacelar de AthaydeJosé Ricardo Bandeira de Oliveira FilhoGeraldo Lorenzi-FilhoPedro Rodrigues GentaPublished in: Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia (2019)
Obesity hypoventilation syndrome (OHS) is defined as the presence of obesity (body mass index ≥ 30 kg/m²) and daytime arterial hypercapnia (PaCO2 ≥ 45 mmHg) in the absence of other causes of hypoventilation. OHS is often overlooked and confused with other conditions associated with hypoventilation, particularly COPD. The recognition of OHS is important because of its high prevalence and the fact that, if left untreated, it is associated with high morbidity and mortality. In the present review, we address recent advances in the pathophysiology and management of OHS, the usefulness of determination of venous bicarbonate in screening for OHS, and diagnostic criteria for OHS that eliminate the need for polysomnography. In addition, we review advances in the treatment of OHS, including behavioral measures, and recent studies comparing the efficacy of continuous positive airway pressure with that of noninvasive ventilation.
Keyphrases
- positive airway pressure
- obstructive sleep apnea
- sleep apnea
- weight gain
- metabolic syndrome
- insulin resistance
- body mass index
- weight loss
- type diabetes
- physical activity
- chronic obstructive pulmonary disease
- case report
- depressive symptoms
- high resolution
- molecularly imprinted
- solid phase extraction
- sleep quality
- respiratory failure
- extracorporeal membrane oxygenation